• OPEN AN ACCOUNT
Indian Indices
Nifty
25,219.90 159.00
(0.63%)
Sensex
82,726.64 539.83
( 0.66%)
Bank Nifty
57,210.45 454.45
( 0.80%)
Nifty IT
36,951.50 92.60
( 0.25%)
Global Indices
Nasdaq
44,522.97 178.89
(0.40%)
Dow Jones
6,330.72 4.12
(0.07%)
Hang Seng
41,246.34 1,471.42
(3.70%)
Nikkei 225
9,061.49 37.68
(0.42%)
Forex
USD-INR
86.23 0.09
(0.10%)
EUR-INR
100.56 0.44
(0.44%)
GBP-INR
116.06 0.57
(0.49%)
JPY-INR
0.58 0.00
(0.80%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
79.48
175509.24
EPS(TTM)
Face Value()
Div & Yield %
83.18
2
0.45
 

Shree Ganesh Biotech India reports standalone net loss of Rs 0.95 crore in the March 2025 quarter
May 23,2025
Net loss of Shree Ganesh Biotech India reported to Rs 0.95 crore in the quarter ended March 2025 as against net profit of Rs 0.54 crore during the previous quarter ended March 2024. Sales declined 20.37% to Rs 3.01 crore in the quarter ended March 2025 as against Rs 3.78 crore during the previous quarter ended March 2024.

For the full year,net profit declined 54.84% to Rs 0.28 crore in the year ended March 2025 as against Rs 0.62 crore during the previous year ended March 2024. Sales rose 13.21% to Rs 22.96 crore in the year ended March 2025 as against Rs 20.28 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales3.013.78 -20 22.9620.28 13
OPM %-47.18-13.76 --4.57-1.04 -
PBDT-0.950.54 PL 0.390.85 -54
PBT-0.950.54 PL 0.390.85 -54
NP-0.950.54 PL 0.280.62 -55